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7CASE REPORT Open AccessWarthin’s tumor of the larynx: a very rare
case and systematic review of the literature
Lluís Nisa1,2,3, Basile Nicolas Landis1,4, Cinzia Salmina1, Angeliki Ailianou5, Eva Karamitopoulou6 and Roland Giger1*Abstract
Background: Warthin’s tumor or cystadenolymphoma (CAL) is a benign salivary gland tumor occurring almost
exclusively in the parotid gland. CALs of other locations are rare.
Case presentation: We report a laryngeal CAL detected in a positron emission tomography/computed tomography
(PET/CT) performed for breast cancer follow-up. The tumor was successfully treated by transoral surgery.
Discussion: Only 14 cases of laryngeal CAL are reported worldwide. These cases confirmed our experience of an
uncomplicated and mostly successful transoral resection.
Conclusion: CALs of the larynx are very rare. They are characterized by hypermetabolism in PET/CT. The increasing use
of PET/CT investigations in cancer patients could give rise to more incidental findings of CALs at unusual locations such
as the larynx.
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LarynxBackground
Laryngeal tumors are predominantly malignant, with
squamous cell carcinoma being the most frequent histo-
pathological entity. Benign tumors represent around 5 %
of all laryngeal tumors, and most of these are papillomas
(more than 80 %).
Cystadenolymphoma (CAL) is a benign tumor of the
salivary glands, also known as Warthin’s tumor or papillary
cystadenoma lymphomatosum. CAL affects most often the
parotid gland, and is the second most frequent benign
salivary gland tumor following pleomorphic adenoma.
CALs represent about 10 % of all salivary gland tumors,
are most prevalent after the 6th decade of life, have a male
predominance, and are more common in smokers. In
general, salivary gland tumors of the larynx are rare and
malignant forms prevail. Benign salivary gland tumors of
the larynx are very rare and therefore poorly documented,
despite claims that oncocytic lesions occur more frequently
than previously thought [1].
The aim of the present article is to report a case of supra-
glottic CAL and review all cases of laryngeal CALs in the* Correspondence: roland.giger@insel.ch
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creativecommons.org/publicdomain/zero/1.0/literature in order to discuss presentation, histological
features, management and outcome.Case presentation
A 61-year-old woman was treated for a lobular carcinoma
of the left breast in 2010. She had been disease-free
since the end of treatment, but the 2-year follow-up
18 F-fluorodeoxyglucose positron emission tomography/
computed tomography (PET/CT) showed increased
uptake on the left supraglottic region (Fig. 1). With the
exception of some intermittent episodes of hoarseness in
the recent past, she was without symptoms. The patient is
an active smoker and free of professional or environmental
exposures.
Transnasal fiberoptic laryngoscopy revealed a 2 x 1 cm
expansive mass involving the left side of the supraglottis.
Vocal fold mobility was unaffected. A direct laryngoscopy
under general anesthesia was performed (Fig. 2) for biopsy,
which revealed a CAL. Complete endoscopic examination
of the upper aerodigestive tract was otherwise normal. An
MRI showed a 2 × 1 × 3.5 cm multi-cystic lesion of
the left supraglottic region (Fig. 3). Therapeutic exci-
sion was performed endoscopically under suspension
microlaryngoscopy using CO2 laser. Histopathologicle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Fig. 1 18F-FDG-PET/CT of the larynx. Intense FDG uptake in the left
supraglottic region (arrowhead). a) axial, b) coronal
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diagnosis of a CAL (Fig. 4). The follow-up was com-
plicated by edema of the involved aryepiglottic fold
causing moderate dysphagia three months after sur-
gery. A second CO2 laser resection under suspension
microlaryngoscopy was performed in order to resect
inflammatory and edematous tissue. Further follow-up
was uneventful, without any symptoms or signs of recur-
rence after 2 years.Fig. 2 Direct laryngoscopy. A 2 × 1 cm expansive mass on the left
side of the supraglottis (arrowhead; asterisk = anterior commissure)
Fig. 3 Fat-suppressed T2 weighted MRI of the larynx. Multi-cystic
hyperintense lesion occupying the left supraglottic region (arrowhead).
a) axial, b) coronalDiscussion
We report a case of CAL of the supraglottic larynx
identified via PET/CT done within the frame of breast
cancer follow-up. Additionally, in order to obtain more
relevant information on this seemingly rare entity, we per-
formed a literature review without language restriction.
Articles were searched in PubMed (up to June 2014) with
the following terms: [(adenolymphoma OR lymphomatous
cystadenoma OR cystadenolymphoma OR papillary cysta-
denoma lymphomatosum OR Warthin) AND (larynx OR
laryngeal)], and with available cross-linked references
from the articles found. We identified 12 eligible articles
that reported 14 cases of true laryngeal CAL, histologically
Fig. 4 Histopathology of the laryngeal cystadenolymphoma. H&E
staining of the laryngeal CAL showing oncocytic epithelium (arrowhead)
surrounded by lymphoid stroma (asterisk) (magnification 40×)
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and lymphoid stroma (Warthin’s tumor). Available
clinical data were extracted from these articles [2-13]
and summarized in Table 1. Our case was added for
analysis purposes.
Male to female ratio was 2:13, and patients’ mean age
was of 64.2 ± 10.99 years (range: 45–80). The clinical
presentation was not disease–but organ-specific, reflecting
laryngeal involvement, with hoarseness as leading
symptom in 7, dyspnea in 3, and dysphagia in 2 patients.
One patient presented with neck swelling. The location
was exclusively supraglottic, with glottic involvement in
only one of the cases. One case showed a bilateral CAL.
Two patients presented CAL within a laryngocele. Tumor
size ranged between 1 and 4.5 cm. In 2 cases, synchronous
CALs of the parotid gland were seen. Transoral resection
was performed in 9 out of 11 patients, and 2 underwent
open transcervical resection. In most cases (9 out of 11
reported) one surgical procedure was sufficient to eradicate
the tumor, whereas in one case 4 operations were needed
for recurrent disease and the second case showed tumoral
persistence after 4 months. Our case underwent a second
operation due to persistent supraglottic edema with no
residual CAL during definitive histopathologic examin-
ation. Another 2 cases showed persistent laryngeal edema
postoperatively.
In summary, laryngeal CAL is very rare and can most
often be managed with transoral resection. Recurrence
seems to be an exception in the larynx and only few
complications or side effects of the treatment are
reported. The unique feature of our reported case is
that the patient’s CAL was detected incidentally due
to regular PET/CT follow-up investigation for a pre-
viously treated breast cancer. Only retrospective
inquiry showed minor laryngeal symptoms consisting of
some hoarseness episodes. Accurate diagnosis requiresnonetheless histopathologic examination of the resected
specimens. Malignant degeneration of CALs, originating
from both the epithelial and the lymphoid compartments,
is a rare but possible event. In the specific case of laryn-
geal CALs, no case of malignant degeneration could be
identified.
Workup with PET/CT has been shown to indicate
false positive results in head and neck cancer patients
showing a CAL within neck lymph nodes mimicking a
metastasis [14]. There was similarity with our case,
where FDG-uptake was found in the larynx, and initially
mistaken for a breast cancer metastasis. Van der Wal et al.
described the largest series of laryngeal CALs (3 cases)
along with seven other cases of extraparotideal CALs
(cheek, oropharynx, palate, buccal fold, lower lip, subman-
dibular gland) [11]. As CALs show a hypermetabolism in
PET/CT exams, which are increasingly performed, future
PET findings might bring new insight regarding synchron-
ous and multiple Warthin’s tumor locations and into
pathogenesis of this particular tumor. While some authors
have classically considered CAL to be more similar to a
reactive process than to a true neoplasia, the views
on pathogenesis have evolved over the last decades.
Current techniques show that the epithelial portion of
a substantial subset of CALs is monoclonal and
frequently harbors a translocation between chromo-
somes 11 and 19 t (11;19), which in turn results in
the fusion oncogene CRTC1-MAML2 [CREB(cAMP
response element-binding protein)-regulated transcription
co-activator 1–mastermind-like protein 2], which is a
master key involved in several signaling pathways that
contribute to cell survival and proliferation, primarily the
Notch pathway [15]. Van der Wal et al. underlined
the fact that laryngeal CALs are indeed rare tumors
and pathologic diagnosis can be challenging, especially
when it comes to distinguishing CAL from oncocytic
hyperplasia or metaplasia, pointing out that the only
basic difference between these entities is the lack of
lymphoid stroma in oncocytic lesions [11].
Another interesting point is the potential multifocal
presentation of CALs. We found 2 cases of concomi-
tant involvement of the larynx and the parotid gland
(Table 1) [9, 12]. This is not a new finding, as syn-
chronous or metachronous development of CALs in
both parotid glands is not a rare event, which raises
the question if there is a need for long-term follow-up in
patients with CALs in general. Although speculative
in nature, we feel that careful workup in incidental
PET/CT findings could reveal a previously underestimated
amount of extra-salivary and multiple synchronous
CAL cases. In light of the open questions regarding
the pathogenesis of CALs, more cases as the present
ones could bring further insight into the nature of this
special benign tumor.
Table 1 Summary of published cases of laryngeal cystadenolymphoma
Authors Age (years)/
Sex
Presentation Location/Histologic
features
Maximal
size (cm)
Other involved
sites
Surgical approach Nbr. of
operations
Outcome Time of follow-up
(months)
Comments
Heinz (1951) [2] 80/F NR Supraglottic 2.5 None Transoral
debulking
1 Persistence 4 -
Barbaccia et al. (1956) [3] NR/M Dyspnea Supraglottic NR None Tracheotomy,
transcervical
resection
1 FR 1 -
Tiwari and Williams (1969) [4] 72/F Neck swelling Supraglottic/within
a laryngocele
4.5 None Transcervical
resection
1 FR NR -
Drut et al. (1975) [5] 70/F Hoarseness Supraglottic NR None Transoral
resection
1 FR NR -
Foulsham et al. (1980) [6] 66/F Hoarseness Supraglottic 1 None Transoral
resection
1 FR 12 Melkersson
syndrome
6 years before
Engel et al. (1987) [7] 61/F NR NR NR None Transoral
resection
1 NR NR -
Evans et al. (1989) [8] 45/F Hoarseness Supraglottic NR None Transoral
resection
4 Recurrence, persistent
supraglottic edema
NR -
Loennecken (1989) [9] 77/F Hoarseness
Dyspnea
Supraglottic/within
a laryngocele
2 Parotid gland Transoral
resection
1 Persistent
supraglottic edema
NR -
Tomik et al. (1991) [10] 72/F Hoarseness
Dyspnea
Supraglottic – glottic NR None Transoral
resection
1 FR 6 -
van der Wal et al. (1993) [11] 54/M NR NR NR None NR NR NR NR -
50/F NR NR NR NR NR NR NR NR
50/F NR NR NR NR NR NR NR NR
Pätz and Möbius (1997) [12] 74/F Dysphagia Supraglottic NR Parotid gland Transoral
resection
1 FR NR -
Jordan et al. (1999) [13] 67/F Hoarseness
Dysphagia
Supraglottic
bilaterally/within
a laryngocele
3 / 2 None NR 1 FR NR -
Present report (2014) 61/F Hoarseness Supraglottic 3.5 None Transoral
resection
2 Persistent
supraglottic edema
24 -
Abbreviations: M – male; F – female; FR – full recovery; NR – not reported
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Warthin’s tumors of the larynx are very rare. Transoral
resection seems to be feasible for most cases, has little
side effects, and is most often curative. As Warthin’s
tumors show increased FDG-uptake similar to malignant
tumors, it is hypothesized that with increasing PET/CT
use, the number of Warthin’s tumor case reports outside
the salivary glands may augment.
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